Meso-Scale Particle Image Velocimetry Studies of Neurovascular Flows In Vitro
December 3rd, 2018
7.6K views
Here we present simplified methods for fabricating transparent neurovascular phantoms and characterizing the flow therein. We highlight several important parameters and demonstrate their relationship to field accuracy.
Overview
This article presents simplified methods for fabricating transparent neurovascular phantoms and characterizing the flow within them. The study emphasizes key parameters that influence field accuracy.
Key Study Components
Area of Science
- Bioengineering
- Hemodynamics
- Neurovascular modeling
Background
- Understanding hemodynamics is crucial for the development of intervascular devices.
- Existing equipment in bioengineering labs can be utilized for this technique.
- Reducing barriers for non-experts is essential for advancing research.
- Transparent phantoms can aid in visualizing flow dynamics.
Purpose of Study
- To provide accessible methods for fabricating neurovascular phantoms.
- To characterize flow dynamics in a simplified manner.
- To enhance the accuracy of bioengineering experiments.
Methods Used
- Mixing PDMS prepolymer base with curing agent in a 10:1 ratio by weight.
- Using a vacuum desiccator for de-gassing the mixture.
- Applying cyclic pressurization and depressurization to facilitate bubble rupture.
- Fabricating phantoms with volumes up to 50 cubic centimeters.
Main Results
- The methods demonstrated effective fabrication of transparent phantoms.
- Flow characterization was successfully achieved.
- Key parameters were identified that relate to field accuracy.
- The technique is accessible for non-experts in bioengineering.
Conclusions
- This study provides a simplified approach to neurovascular phantom fabrication.
- It highlights the importance of key parameters in flow characterization.
- The methods can enhance research in hemodynamics and device interactions.
Frequently Asked Questions
What is the main advantage of this technique?
The main advantage is that it utilizes equipment commonly found in bioengineering labs, lowering the barrier for non-experts.
How is the PDMS mixture prepared?
The PDMS prepolymer base is mixed with curing agent in a 10:1 ratio by weight.
What is the purpose of using a vacuum desiccator?
It is used to de-gas the mixture and minimize bubble entrapment.
What volume of phantoms can be fabricated?
Phantoms with volumes up to 50 cubic centimeters can be fabricated.
What role do cyclic pressurization and depressurization play?
They facilitate bubble rupture during the fabrication process.
How does this study contribute to bioengineering?
It provides accessible methods for studying hemodynamics and their interactions with intervascular devices.
Executive Industry Relevance
Mesoscale particle image velocimetry (PIV) using accessible, low-cost phantoms enables precise quantification of neurovascular flows in vitro, supporting early-stage device and therapeutic hypothesis testing. By reducing reliance on specialized instrumentation and expensive commercial phantoms, this approach broadens access to quantitative hemodynamic modeling and de-risks early discovery decisions. The protocol's compatibility with standard bioengineering lab resources enhances portfolio-wide reproducibility and translational continuity for neurovascular R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables quantitative interrogation of neurovascular flow hypotheses in controlled, reproducible systems.
- Supports mechanistic de-risking for device-tissue and flow-mediated target validation.
- Facilitates predictive confidence in early-stage neurovascular intervention strategies.
Screening & Assay Development
- Provides standardized, customizable phantoms for assay development and flow-based screening.
- Delivers reproducible, quantitative velocity field outputs for comparative evaluation of device or compound effects.
- Enables scalable assay workflows using open-source image analysis and widely available lab equipment.
Translational & Preclinical Research
- Aligns in vitro flow models with disease-relevant neurovascular geometries for translational biomarker exploration.
- Supports continuity from discovery through preclinical validation by enabling iterative, quantitative flow studies.
- Reduces translational risk by providing physiologically relevant flow data for device and therapeutic evaluation.
Pipeline & Workflow Integration
This protocol integrates from early discovery through preclinical research, enabling iterative hypothesis testing, assay development, and translational modeling within the neurovascular R&D pipeline.
- Discovery Biology: Quantitative flow visualization supports hypothesis-driven target validation and mechanistic de-risking.
- Screening: Standardized phantoms and open-source analysis enable reproducible, scalable assay workflows.
- Analytics: Provides velocity field measurements and statistical outputs for robust condition comparison.
- Translational Research: Facilitates alignment with disease-relevant neurovascular models for preclinical continuity.
- Enterprise Reuse: Open-source and low-cost design supports broad adoption and cross-program standardization.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in neurovascular flow studies.
- Operational Value: Lowers cost, increases reproducibility, and enables rapid prototyping of flow models.
- Strategic Value: Improves go/no-go decision quality and capital efficiency in early neurovascular R&D.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of device and therapeutic candidates.
Implementation Considerations
- Requires expertise in 3D printing, silicone casting, and open-source image analysis tools.
- Needs access to standard bioengineering lab instrumentation and fluorescence microscopy.
- Demands rigorous cross-team standardization of phantom fabrication and image processing protocols.
- Adaptable across neurovascular and other mesoscale flow model systems with protocol modifications.
- Careful handling of solvents and attention to signal noise are critical for data fidelity and safety.
Biopharma FAQs
Why does null hypothesis testing matter for neurovascular flow quantification?
Null hypothesis testing enables objective evaluation of whether observed flow differences in PIV studies are statistically significant, supporting robust target validation and mechanistic de-risking in neurovascular R&D.
How does independent variable isolation fit in PIV-based device assessment?
Isolating variables such as flow rate or device geometry in the phantom system allows teams to attribute observed velocity field changes directly to specific interventions, increasing predictive confidence in early discovery workflows.
What do quantitative velocity field measurements enable in neurovascular modeling?
Quantitative velocity fields provide reproducible, high-resolution data for comparing device or intervention effects, supporting assay development and cross-condition benchmarking in neurovascular research.
Why are replication requirements critical for cross-functional PIV studies?
Replication ensures that velocity field outputs and flow characterizations are reproducible across teams and experiments, enabling reliable data sharing and collaborative decision-making in multi-disciplinary R&D environments.
What statistical analysis capabilities are needed before implementing PIV workflows?
Teams must establish protocols for image calibration, noise reduction, and vector field validation to ensure that statistical comparisons of flow data are accurate and actionable for portfolio advancement decisions.
Chapters in this video
0:04
Title
0:30
PDMS-based Vascular Phantom and Mock Blood Solution Fabrication
3:32
Video Collection
4:42
Image Processing
6:27
Results: Fabrication of Vascular Phantom and Changes in Vector Field Fidelity with Varying Post-Processing Techniques
7:26
Conclusion
